These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 20307220)

  • 21. Allergic contact dermatitis from timolol and dorzolamide eye drops.
    Kalavala M; Statham BN
    Contact Dermatitis; 2006 Jun; 54(6):345. PubMed ID: 16787459
    [No Abstract]   [Full Text] [Related]  

  • 22. Hyaluronic acid modified chitosan nanoparticles for effective management of glaucoma: development, characterization, and evaluation.
    Wadhwa S; Paliwal R; Paliwal SR; Vyas SP
    J Drug Target; 2010 May; 18(4):292-302. PubMed ID: 19943753
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Ocular pulse amplitude, intraocular pressure and beta blocker/carbonic anhydrase inhibition in combined therapy of primary open-angle glaucoma].
    Schmidt KG; von Rückmann A; Becker R; Pillunat LE
    Klin Monbl Augenheilkd; 1999 Dec; 215(6):361-6. PubMed ID: 10637801
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The dorzolamide/timolol combination versus timolol plus pilocarpine: patient preference and impact on daily life. United States Patient Preference Study Group. International Patient Preference Study Group.
    Sverrisson T; Gross R; Pearson J; Rusk C; Adamsons I
    J Glaucoma; 1999 Oct; 8(5):315-24. PubMed ID: 10529932
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Use of fixed-dose combination drugs for the treatment of glaucoma.
    Khouri AS; Realini T; Fechtner RD
    Drugs Aging; 2007; 24(12):1007-16. PubMed ID: 18020533
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparative acute effects of brimonidine 0.2% versus dorzolamide 2% combined with beta-blockers in glaucoma.
    Centofanti M; Manni G; Gregori D; Cocco F; Lorenzano D; Bucci MG
    Graefes Arch Clin Exp Ophthalmol; 2000 Apr; 238(4):302-5. PubMed ID: 10853928
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Innovative glaucoma therapy. Glaucoma therapy with topical carbonic anhydrase inhibitors].
    Herkel U; Pfeiffer N
    Ophthalmologe; 2001 Oct; 98(10):929-33. PubMed ID: 11699313
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of the efficacy on intraocular pressure and retinal blood flow of a beta-blocker (timolol maleate) against the fixed association of a topical carbonic anhydrase (dorzolamide) and a beta-blocker (timolol maleate).
    Brogliatti B; Rolle T; Vizzeri GM; Cipullo D
    Acta Ophthalmol Scand Suppl; 2000; (232):47-9. PubMed ID: 11235534
    [No Abstract]   [Full Text] [Related]  

  • 29. [Use of glaucoma medications during pregnancy and breastfeeding].
    Méndez-Hernández C
    Arch Soc Esp Oftalmol; 2012 Dec; 87(12):389-91. PubMed ID: 23121698
    [No Abstract]   [Full Text] [Related]  

  • 30. Dorzolamide/timolol combination versus concomitant administration of brimonidine and timolol: six-month comparison of efficacy and tolerability.
    Sall KN; Greff LJ; Johnson-Pratt LR; DeLucca PT; Polis AB; Kolodny AH; Fletcher CA; Cassel DA; Boyle DR; Skobieranda F
    Ophthalmology; 2003 Mar; 110(3):615-24. PubMed ID: 12623832
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A comparison of dorzolamide-timolol combination versus the concomitant drugs.
    Choudhri S; Wand M; Shields MB
    Am J Ophthalmol; 2000 Dec; 130(6):832-3. PubMed ID: 11124307
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The hypotensive efficacy of dorzolamide HCL-timolol maleate 0.50% vs concomitant use of the two drugs.
    Durante A; Aurilia P; Guarnaccia G; Boles Carenini B
    Acta Ophthalmol Scand Suppl; 2000; (232):46. PubMed ID: 11235533
    [No Abstract]   [Full Text] [Related]  

  • 33. A clinical trial of MK-507, Trusopt, for raised intraocular pressure--the Australian experience.
    Gillies WE; Brooks AM
    Aust N Z J Ophthalmol; 1996 May; 24(2):111-5. PubMed ID: 9199740
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [New drugs in glaucoma therapy].
    Gramer E
    Klin Monbl Augenheilkd; 1998 Jul; 213(1):aA10-2. PubMed ID: 9743931
    [No Abstract]   [Full Text] [Related]  

  • 35. Brinzolamide 1%/timolol 0.5%: safety and efficacy of a new fixed-combination IOP-lowering product for glaucoma.
    Januleviciene I
    Curr Med Res Opin; 2010 Nov; 26(11):2575-8. PubMed ID: 20868340
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A multicenter study comparing dorzolamide and pilocarpine as adjunctive therapy to timolol: patient preference and impact on daily life.
    Strohmaier K; Snyder E; Adamsons I
    J Am Optom Assoc; 1998 Jul; 69(7):441-51. PubMed ID: 9697378
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of topical 0.5% levobunolol alone or in association with 2% dorzolamide compared with a fixed combination of 0.5% timolol and 2% dorzolamide on intraocular pressure and heart rate in dogs without glaucoma.
    Scardillo A; Pugliese M; De Majo M; Niutta PP; Pugliese A
    Vet Ther; 2010; 11(3):E1-6. PubMed ID: 20960417
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ongoing clinical assessment of the safety profile and efficacy of brimonidine compared with timolol: year-three results. Brimonidine Study Group II.
    Melamed S; David R
    Clin Ther; 2000 Jan; 22(1):103-11. PubMed ID: 10688394
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Two-year safety study of dorzolamide as monotherapy and with timolol and pilocarpine. Dorzolamide Safety Study Group.
    Adamsons IA; Polis A; Ostrov CS; Boyle JE
    J Glaucoma; 1998 Dec; 7(6):395-401. PubMed ID: 9871861
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy and safety of brimonidine and dorzolamide for intraocular pressure lowering in glaucoma and ocular hypertension.
    Katz LJ; Simmons ST; Craven ER
    Curr Med Res Opin; 2007 Dec; 23(12):2971-83. PubMed ID: 17949534
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.